The research, led by A.R. Thomas and L.N. Trulsen alongside senior author P.T. Levy and colleagues, applied video-based assessment to delivery room stabilization of newborns with prenatally diagnosed congenital heart disease. The approach borrows from a methodology that has gained traction in adult resuscitation and trauma care over the past two decades but has been applied far more sparingly in neonatology. Rather than relying on the retrospective, often incomplete documentation that clinicians enter into electronic health records after the fact, the investigators analyzed synchronized audiovisual recordings of actual stabilization events, capturing what was done, when it was done, in what sequence, and how the team communicated throughout. The contrast between what the videos show and what the charts record forms the conceptual heart of the paper, reflected in its subtitle: “Insights beyond chart review.”

The clinical stakes of delivery room management for infants with congenital heart disease are considerable. Unlike the general neonatal population, these babies frequently require a highly individualized approach to the first minutes of life. Some lesions, such as hypoplastic left heart syndrome or critical aortic stenosis, depend on ductal patency to maintain systemic blood flow, making timely prostaglandin initiation essential. Others, including transposition of the great arteries with restrictive atrial communication, may require urgent balloon atrial septostomy within hours. Many benefit from careful titration of oxygen, because hyperoxia can precipitously drop pulmonary vascular resistance in ways that steal systemic output, while hypoxia risks failed transition. Standard neonatal resuscitation algorithms, designed primarily for term infants without known cardiac lesions, must therefore be adapted, and the degree to which teams actually adapt them in real time has been almost impossible to measure with conventional methods.

Chart review, the standard instrument of quality improvement in neonatology, suffers from well-documented limitations. Documentation is typically written minutes to hours after the event, by multiple team members, and is heavily shaped by what is required for billing and medico-legal protection. Time intervals are frequently rounded or estimated. Deviations from protocol, hesitations, communication breakdowns, and near-misses rarely appear in the record unless they result in obvious harm. Clinical trials of resuscitation interventions have repeatedly shown that chart-derived timing data diverge substantially from objective measurements. The Journal of Perinatology study leverages this known gap as its central analytical opportunity, asking specifically whether the stabilization of cardiac neonates, a population in whom precise sequencing and dosing matter enormously, is documented accurately enough to support quality improvement, and what additional knowledge video review can extract.

Video-based assessment in neonatal care has precedent. The Neonatal Resuscitation Program and various international registries have supported recording of resuscitations, and studies from centers in the United States, Europe, and Australia have used video to examine delay to ventilation, bag-mask technique, heart rate assessment, and thermal management. However, most of this work has focused on general resuscitation or extremely preterm infants. Applying the method specifically to newborns with prenatal cardiac diagnoses represents a meaningful extension, because it allows researchers to evaluate whether the elaborate pre-delivery planning that characterizes fetal cardiac programs translates into delivery room execution. The multidisciplinary nature of these deliveries, often involving neonatology, pediatric cardiology, obstetrics, and nursing simultaneously, makes communication and role clarity especially important and especially difficult to capture in narrative notes.

The methodology described by Thomas and colleagues involves recording delivery room events with cameras positioned to capture the infant, the resuscitation team, and available monitors, with audio capturing verbal commands, heart rate announcements, and medication preparation. Trained reviewers then code the recordings against structured checklists, often second-by-second, generating a timeline of interventions that can be aligned with physiological data from the monitors. Inter-rater reliability is established through independent dual coding of subsets of recordings. This produces a granular dataset: time from birth to initial assessment, time to adequate heart rate detection, duration and quality of positive pressure ventilation, oxygen concentration used, timing of prostaglandin administration when indicated, and the frequency of deviations from the pre-delivery care plan. None of these elements can be reconstructed with comparable fidelity from chart review alone.

What emerges from such analyses, according to the study’s framing, is a series of insights that chart review structurally cannot provide. Video reveals how often the planned stabilization steps occur in the intended order, and how frequently competing demands, such as an unexpectedly depressed infant requiring immediate ventilation while the cardiac team awaits arrival, force improvisation. It exposes differences between what teams say they will do during prenatal counseling and what actually unfolds. It quantifies interruptions, hesitations, and handoff ambiguities that never reach the medical record. And it provides a basis for constructive, non-punitive debriefing, which many centers that have adopted video review cite as one of its greatest values: teams see themselves as others see them, and targeted coaching follows naturally.

The implications for cardiac neonates are particularly significant because of the population’s fragility and the centrality of early physiology to long-term outcomes. Studies of infants with ductal-dependent lesions have shown that delays in prostaglandin infusion or inappropriate oxygen exposure in the delivery room can initiate a cascade of end-organ injury that shapes neurodevelopmental trajectories long before surgical repair. Preoperative clinical status at the time of surgery is one of the strongest predictors of outcomes in single-ventricle palliation and other complex repairs. If video-based assessment identifies modifiable delivery room practices, delayed recognition of cyanosis, suboptimal ventilatory strategy, medication preparation delays, communication failures between subspecialty services, then it offers a direct lever on downstream outcomes for a population in whom even small physiological improvements may compound over a lifetime.

The study also speaks to a broader methodological transition in perinatal quality improvement. The traditional quality cycle, in which chart-based audits feed committee review and revised protocols, has produced genuine but incremental gains. Video-based assessment closes a feedback loop that has historically been open, replacing inference with observation. In adult medicine, this transition has already changed practice; in neonatology, ethical and logistical barriers, including consent, privacy, storage, and the emotional weight of recording the most vulnerable moments of a family’s life, have slowed adoption. The Journal of Perinatology paper contributes to the growing evidence that these barriers can be managed and that the scientific yield justifies the effort, particularly for high-risk subpopulations where delivery room performance is a decisive determinant of trajectory.

There are, of course, important caveats that the authors and the field must navigate. Video review is resource-intensive; coding recordings requires trained personnel and time. Single-center studies may reflect local team structures, staffing models, and equipment that do not generalize. The presence of cameras, even with staff habituation, can alter behavior, although evidence suggests this effect attenuates quickly. Consent processes must be transparent and must address the possibility that recordings could surface deficiencies in care. And most fundamentally, video identifies what happened, not always why; linking observed deviations to outcomes requires larger, multicenter cohorts with adequate follow-up. The current study should be understood as an early and careful step in that direction, establishing feasibility and highlighting the magnitude of the gap between documentation and reality rather than definitively quantifying outcome associations.

For clinicians in fetal cardiac programs, the practical message is sobering but constructive. The prenatal diagnosis, the delivery planning meeting, and the scripted stabilization plan are necessary but not sufficient. Execution in the delivery room is a distinct skill set, one that can be rehearsed through simulation, refined through video-informed debriefing, and monitored with objective metrics. For families, the study is a reminder that the highest standard of care for a baby with prenatally diagnosed heart disease involves not only expert imaging and surgical planning but disciplined attention to the first minutes of life, where the transition from fetal to neonatal circulation determines whether the carefully constructed plan has a chance to succeed. And for the research community, the work by Thomas, Trulsen, Levy, and their colleagues adds congenital heart disease to the list of conditions for which the delivery room recorder may prove as informative as the chart, and considerably more honest.

As video-based assessment continues to spread through neonatology, the field will face choices about how widely to record, how to govern the data, and how to convert observation into sustained practice change. What this study makes clear is that for newborns with congenital heart disease, a population in whom every minute and every concentration of inspired oxygen matters, understanding stabilization “beyond chart review” is not a luxury but a necessity. The recordings reviewed here suggest that the gap between what is documented and what is done is wide enough to matter, and closing that gap may be one of the most direct paths available to improving outcomes for these infants in their most vulnerable hours.

The report underscores the intricate interplay between viral infections and heart function, particularly in children already predisposed to cardiac abnormalities. These patients, already grappling with congenital heart issues, were given remdesivir as part of their treatment regimen against viral complications. However, the unforeseen side effects manifested as dramatic declines in heart function, raising critical alarms about the medication’s safety profile for vulnerable populations, particularly those with underlying cardiovascular challenges.

As the medical community continuously seeks effective treatments for viral infections, the findings from this case serve as a poignant reminder of the potential risks associated with even standard therapies like remdesivir. The researchers meticulously outlined the patients’ clinical histories, treatment processes, and the subsequent development of myocardium suppression—providing a detailed account that illuminates the complexities of managing comorbidities in pediatric patients.

Myocardium suppression refers to a reduction in the heart’s ability to effectively pump blood, a condition that can lead to various complications, including heart failure. In both patients, pronounced signs of myocardial distress were observed, including altered cardiac indices and clinical symptoms indicative of heart failure. These findings prompt a re-evaluation of the conventional understanding of remdesivir’s safety, particularly for children and those with pre-existing heart problems.

As the cases unfolded, the researchers employed various diagnostic tools, including echocardiograms and biomarkers, to assess the extent of cardiac involvement. The data collected revealed a significant decline in left ventricular function, which poses serious ethical questions regarding the administration of remdesivir to patients with congenital heart disease. The implications extend beyond these individual cases, indicating a need for additional research to thoroughly investigate the cardiovascular risks associated with remdesivir in pediatric populations.

The authors of the report call for heightened awareness among healthcare practitioners when prescribing antiviral treatments to children with congenital heart defects. This need for vigilance fosters a broader discourse about the importance of individualized care, particularly for patients with complex health histories. The documented cases urge clinicians to balance the benefits of antiviral treatment with the potential for severe adverse effects, ensuring that they are making informed decisions in the best interests of their patients.

It is worth noting that while the cases reported are alarming, they are also a critical doorway into exploring the multifaceted relationship between viral infections and cardiac health. Cardiologists and infectious disease specialists must collaborate to better understand these interactions and develop comprehensive treatment protocols that prioritize patient safety, particularly in high-risk groups.

Moreover, the report highlights a critical gap in knowledge regarding the pharmacodynamics of remdesivir in patients with pre-existing myocardium stress. The nuances of how antiviral medications interact with underlying cardiac conditions warrant further investigation, providing a foundation for future studies aimed at elucidating these complex mechanisms.

In this context, ongoing clinical trials and research initiatives must extend their scope to include cardiovascular monitoring and assessment in pediatric participants receiving remdesivir and similar antiviral therapies. Such efforts are fundamental to safeguarding patient health and aligning treatment protocols with emerging data on drug safety and efficacy.

As the research progresses, it becomes clear that the need for collaborative efforts in medical research is more urgent than ever. The intersection of infectious diseases and cardiovascular health presents an evolving challenge, urging professionals across specialties to unite in their approach to patient care.

In conclusion, while remdesivir has shown promise as an antiviral therapy, this case report serves as a stark reminder of the importance of vigilance in its administration, especially in pediatric patients with congenital heart disease. The findings call attention to the necessity for ongoing research that explores the broader implications of such treatments, ensuring that future therapeutic strategies are both effective and safe.

Furthermore, the medical community must strive to maintain an open dialogue, sharing insights and clinical experiences transparently, allowing for an informed consensus on how best to navigate the complexities of treating viral infections in individuals with compromised cardiovascular health.

As awareness grows regarding potential cardiac risks associated with antiviral treatments, it is imperative that healthcare teams remain proactive in both the research and clinical phases, fostering an environment where safety, efficacy, and patient-centered care are the cornerstones of therapeutic decision-making.

In the end, the report serves not only to alert healthcare professionals but also to advocate for comprehensive research, collaborative practices, and the continuous improvement of treatment methodologies to ensure that every patient—regardless of their complex health background—receives the safest and most effective care possible.

Subject of Research: Cardiac effects of antiviral treatment with remdesivir in pediatric patients with congenital heart disease.

Article Title: Severe myocardium suppression in two congenital heart disease patients after remdesivir use – a case report.

Article References: Lin, YF., Fang, SY., Huang, SC. et al. Severe myocardium suppression in two congenital heart disease patients after remdesivir use – a case report. BMC Pediatr 25, 934 (2025). https://doi.org/10.1186/s12887-025-06315-y

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12887-025-06315-y

Keywords: Myocardium suppression, remdesivir, congenital heart disease, cardiovascular health, pediatric patients, antiviral treatment, heart function.

Cardiac CT volumetry is a sophisticated procedure that utilizes three-dimensional (3D) imaging to assess chamber volumes, thus aiding in the diagnosis and management of pediatric patients with congenital heart anomalies. This imaging technique not only enhances visualization of the heart’s anatomy but also allows for a quantifiable analysis of ventricular volumes that can be critical in therapeutic decision-making. The streamlined approach proposed by the authors serves to demystify the complexities involved in volumetric measurements, equipping clinicians with a valuable tool in their ongoing battle against congenital heart diseases.

One of the prominent advantages of using cardiac CT is its ability to generate high-resolution images that convey intricate details about the heart’s structure. The methodology outlined by Goo and Abdul Latiff emphasizes a step-by-step guide that incorporates 3D threshold-based segmentation techniques. This technique is particularly significant as it enables an accurate delineation of the heart chambers, ultimately facilitating better assessment of ventricular function and morphology. In pediatric populations where traditional imaging may pose challenges, CT offers an alternative that combines efficiency and remarkable detail.

The procedural steps initiated in this guide underscore the importance of meticulousness in image acquisition and post-processing. To achieve reliable volumetric results, the authors recommend specific preparatory measures, including optimal patient positioning and the careful selection of imaging protocols. These foundational steps are crucial, as they influence the overall quality and diagnostic utility of the images obtained. Emphasizing patient comfort and safety while ensuring adherence to radiation dose optimization principles is paramount in pediatric cardiac imaging.

Segmentation, the heart of the volumetric analysis, is where innovative software truly shines. The authors highlight software tools capable of automating the delineation of cardiac structures, which not only increases reproducibility but also enhances workflow efficiency. As congenital heart disease often necessitates regular monitoring and assessment, the implementation of automated techniques can significantly reduce the time and effort involved in volumetric calculations, ensuring that medical professionals can focus on patient care and interpretation of results.

Moreover, this 3D threshold-based segmentation approach offers invaluable insights beyond pure volumetric data. By allowing for the visualization of dynamic changes in ventricular volume during the cardiac cycle, the methodology enriches our understanding of ventricular function and can gauge the effectiveness of therapeutic interventions. Recognizing the intricate interplay between anatomy and function is vital for the management of patients with congenital heart defects, and enhanced imaging techniques can provide the requisite data for informed clinical decisions.

As technology continues to advance, the future of cardiac imaging suggests even more improvements in the precision of volumetric assessments. The integration of artificial intelligence (AI) and machine learning into cardiac CT volumetry is on the horizon, a prospect that may promise enhanced accuracy and lower variability in results. The drive towards innovation have far-reaching implications for congenital heart disease management, potentially translating into better outcomes for pediatric patients facing these complex challenges.

Furthermore, the importance of collaborating multidisciplinary teams in the assessment of congenital heart disease cannot be overstated. The insights gleaned from cardiac CT volumetric analyses assist not only cardiologists but also cardiac surgeons and interventionalists in planning and executing treatment strategies. Shared interpretations of imaging results across various specialties foster a comprehensive approach to patient management, which is essential for addressing the multifaceted nature of congenital heart disorders.

What sets this study apart is the authors’ commitment to the educational aspect of cardiac CT volumetry. By providing a clear guide tailored for practical use, they empower physicians and healthcare professionals to apply these techniques confidently in their clinical practice. The dissemination of knowledge about 3D imaging methods is vital in fostering familiarity and expertise among practitioners, ultimately leading to high-quality care for patients with congenital heart disease.

Despite the compelling advantages of cardiac CT in volumetric analysis, it is essential to remain cognizant of certain limitations. Patient selection and the appropriateness of imaging modalities are factors that must be deliberated carefully, as excessive reliance on any singular technique can hinder comprehensive evaluation. Continuous dialogue within the medical community regarding the best imaging practices will be crucial to forming evidence-based guidelines and adapting them to the evolving landscape of pediatric cardiac care.

As this methodology becomes established within various clinical settings, data generated from its application will serve as a foundation for future research endeavors. Understanding longer-term trends in ventricular volumes and function following different interventions can highlight the trajectory of patients with congenital heart conditions, presenting opportunities for improved understanding and management of outcomes in this vulnerable population.

The reference work of Goo and Abdul Latiff stands as a testament to the progressive nature of cardiology in pediatric settings. Their guide is not merely a procedural outline but a significant step towards harmonizing technology and clinical practice in capturing critical cardiac data. For practitioners working to bridge the gap in congenital heart conditions management, the insights offered are essential for embracing innovative methodologies that ultimately lead to enhanced patient care.

As we look to the future of cardiac imaging in congenital heart diseases, the integration of cutting-edge methodologies such as the one presented by Goo and Abdul Latiff will undoubtedly pave the way for more precise and personalized diagnostic strategies. This educational initiative embodies a broader goal within the medical community—to leverage technological advancements for the betterment of patient care, particularly for those born with the challenges posed by congenital heart defects.

With a profound commitment to enhancing pediatric cardiac care, the roadmap laid out for 3D threshold-based segmentation stands to impact medical practice significantly. It challenges practitioners to embrace new technologies, pushing the boundaries of conventional imaging and redefining standards of excellence in the assessment of ventricular volumes in the child with congenital heart disease.

As clinicians adopt these methodologies, one can expect a transformative shift in the strategy employed for managing congenital heart defects, ultimately leading to more successful patient outcomes and improved quality of life for affected children. The future of pediatric cardiac care is unmistakably tied to the progressive application of innovative imaging modalities, and the work by Goo and Abdul Latiff will serve as a cornerstone in this evolution.

Subject of Research: Cardiac computed tomography ventricular volumetry in congenital heart disease.

Article Title: A step-by-step guide for cardiac computed tomography ventricular volumetry using three-dimensional threshold-based segmentation for congenital heart disease.

Article References:
Goo, H., Abdul Latiff, H. A step-by-step guide for cardiac computed tomography ventricular volumetry using three-dimensional threshold-based segmentation for congenital heart disease.
Pediatr Radiol (2025). https://doi.org/10.1007/s00247-025-06409-w

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s00247-025-06409-w

Keywords: cardiac CT, ventricular volumetry, congenital heart disease, 3D imaging, segmentation techniques, pediatric cardiology, patient management, imaging innovation.